Dr. Eniko Manek is the Founder of Teuton Tech, the world’s first Nanoformulation Consulting company. Eniko also acts as Head of Research at a pharmaceutical start-up; as well as scientific advisor at different nanotechnology, biotechnology, IP law and innovation management firms. Currently, Eniko is affiliated with the College of Medicine and Health Sciences, Khalifa University in the United Arab Emirates, while previously she collaborated with the Florida International University in the US.
Eniko holds a PhD in chemistry, an MSc degree in materials science, and a BSc degree in environmental science, and she also has education in executive management, thermal analysis, quality assurance and life cycle assessment. In her early career, Eniko worked at the Budapest University of Technology and Economics as a research associate and as a lecturer in physical chemistry. Subsequently, she transitioned to industry and gained experience in various executive-level positions – such as Board Member, Deputy & Interim CEO, Chief Technology Officer, Head of Nanotechnology Department and Head of Formulation Laboratory – at various enterprises in the US and in the EU that focus on the development and commercialization of nanoformulated pharmaceuticals, agrochemicals and cosmetics. During this time, Eniko also served as board member of the American Chemical Society, Hungary Chapter.
In 2018, Eniko turned her dream into reality and created Teuton Tech, the first and only Nanoformulation Consulting enterprise in the world. At Teuton Tech, Eniko and her team help companies to develop their own nanoformulated products and thus drastically enhance the bioavailability, efficacy, stability and safety of their active ingredients. At present, Eniko’s commercial projects cover the fields of pharmaceuticals, nutritional supplements, cosmetics and agrochemicals; while in her academic studies she concentrates on nano-therapeutics for the treatment of brain diseases.
